| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Sam Schlessinger | EVP General Counsel | 2026-02-07 | 619 | $12.74 | $7.89kSell |
| Paul Schwichtenberg | President and COO | 2026-02-07 | 825 | $12.74 | $10.51kSell |
| Ajay Patel | EVP and CFO | 2026-02-07 | 825 | $12.74 | $10.51kSell |
| David Matthew Stark | Director | 2025-11-10 | 8,959 | $0.76 | $6.81kSell |
| Brendan P. 1. Ogrady | CEO | 2025-05-31 | 49,416 | $0.66 | $32.81kSell |
| Sam Schlessinger | EVP General Counsel | 2025-05-12 | 14,958 | $0.62 | $9.20kSell |
| Paul Schwichtenberg | EVP Chief Transformation Officer | 2025-05-12 | 16,840 | $0.62 | $10.36kSell |
| Ajay Patel | EVP and CFO | 2025-05-12 | 16,840 | $0.62 | $10.36kSell |
| Sam Schlessinger | SVP General Counsel | 2025-02-21 | 7,656 | $0.81 | $6.20kSell |
| Paul Schwichtenberg | SVP Chief Transformation Officer | 2025-02-21 | 8,505 | $0.81 | $6.89kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Nantahala Capital Management LLC | 137.30% | 8,810,073 | $102.90M | Institution |
| Gavin Molinelli | 82.52% | 5,295,270 | $61.85M | Insider |
| Vanguard Group Inc | 68.97% | 4,425,543 | $51.69M | Institution |
| Biovail Laboratories Inc | 66.11% | 4,242,032 | $49.55M | Insider |
| Kevin C. Tang | 59.49% | 3,817,600 | $44.59M | Insider |
| Renaissance Technologies LLC | 45.85% | 2,942,276 | $34.37M | Institution |
| Blackrock Inc | 21.27% | 1,364,701 | $15.94M | Institution |
| Geode Capital Management LLC | 15.93% | 1,022,266 | $11.94M | Institution |
| James A. Schoeneck | 13.91% | 892,840 | $10.43M | Insider |
| Arthur J. Higgins | 11.57% | 742,239 | $8.67M | Insider |